Cash Flow Statement

Amortizatization of Intangibles Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Depreciation & Amortization (CF)Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Net Cash Flow Net Income Non-cash Items Other financing activities Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Income Statement

Others

Ratios

Atea Pharmaceuticals (AVIR) Change in Acquisitions & Divestments (2022)

Atea Pharmaceuticals (AVIR) has 1 years of Change in Acquisitions & Divestments data on record, last reported at $91.9 million in Q4 2022.